UI to participate in clinical trial of COVID-19 vaccine
Date: Tuesday, August 25, 2020
University of Iowa is participating in a large-scale, international clinical trial to study the safety, tolerability, immunogenicity, and efficacy of vaccines against COVID-19. The study is testing an experimental RNA vaccine developed by drug companies BioNTech and Pfizer. Overall, the study aims to enroll approximately 30,000 adults. The UI site will start vaccinations July 30 and hopes to enroll 250 participants.